Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-24 of 30
» View courant.com items only
    Apr 22, 2013 |Story| Reuters

  1. Roche to dissolve Applied Science business

    Reuters
    ZURICH, April 23 (Reuters) - Swiss drugmaker Roche Holding AG said it would dissolve its Applied Science business, leading to 170 job cuts in Germany and the United States as price pressures and funding cuts in life-science research weigh. The Basel-...

    Tags: Science and Technology, Applied Science, IBM

    2. Apr 16, 2013 |Story| Hartford Courant

  2. Thermo Fisher To Buy Life Tech For $13.6 Billion

    Thermo Fisher Scientific Inc. on Monday agreed to buy Life Technologies Corp for $13.6 billion in a deal that would make it one of the top two companies in the hot field of genetic testing. The pact values Life Tech at $76 per share, a 12 percent...

    Tags: Science and Technology, Corporate Officers, Food Industry, Deutsche Bank AG, Sigma-Aldrich Corporation

    3. Dec 13, 2012 |Story| Reuters

  3. More pressure to justify cost of cancer drugs versus benefits

    (Reuters) - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments.
    Reuters
    (Reuters) - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments. In the past, pharmaceutical companies could launch a high-priced drug with little push back. But now, there...

    Tags: Science and Technology, Biotechnology, Corporate Officers, Prices, Pharmaceuticals

    4. Jul 15, 2012 |Story| Reuters

  4. Scientists see AIDS vaccine within reach after decades

    CHICAGO (Reuters) - At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years.
    Reuters
    CHICAGO (Reuters) - At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years. But a string of failed attempts - punctuated by a...

    Tags: Trials, Merck & Company Incorporated, Science and Technology, AIDS, Pharmaceuticals

    5. Feb 1, 2012 | Allentown Morning Call

  5. New help for basal cell skin cancer patients

    Health
    On Monday, the U.S. Food & Drug Administration approved a new drug to treat advanced basal cell carcinoma, the most common form of skin cancer. This is good news for the approximately 2.8 million Americans who will be diagnosed with a basal-cell...
    6. Aug 22, 2011 |Story| Reuters

  6. Seattle Genetics cancer drug price may top $100,000

    The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost.
    Reuters
    The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost. The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first...

    Tags: Science and Technology, Health, Prostate Cancer, Skin Cancer, Drugs and Medicines

    7. May 23, 2011 |Story| Reuters

  7. Vertex Hepatitis-C Drug OK'd, Promising More Cures

    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co.
    Reuters
    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co. Incivek, a pill...

    Tags: Corporate Officers, Merck & Company Incorporated, Liver Disease, Health, Prices

    8. May 26, 2011 |Story| Reuters
  8. |Story
    9. Dec 16, 2010 |Story| Hola Hoy
  9. |Story

    Tags: Washington (U.S. state)

    10. Dec 16, 2010 |Story| Hola Hoy
  10. |Story

    Tags: Washington (U.S. state)

    11. Nov 7, 2009 |Story| Los Angeles Times

  11. New study may deal final blow to acne drug Accutane

    Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition.
    Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition. -------------------- FOR THE RECORD: Accutane's side effects: An article in Saturday's Section A about the possibility of...

    Tags: Ulcerative Colitis, Science and Technology, Pharmaceuticals, Health, Inflammatory Bowel Disease

    12. Jul 23, 2006 |Story| Tribune Media Services

  12. Cisco in position to capitalize on telecom growth

    Tribune Media Services columnist
    Q: I bought shares of Cisco Systems Inc. way back when they were booming. Are they coming back? -- C.G., via the Internet A: You can be confident that the dominant corporate networking company will in the long run benefit from the dramatic worldwide...

    Tags: Marketing, Science and Technology, SanDisk Corporation, Morningstar Incorporated, Finance

< Previous • 1  2  3 • Next >
Original site for Roche Holding AG topic gallery.